Kaydan Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$879K Buy
3,319
+26
+0.8% +$6.86K 0.3% 48
2026
Q2
$836K Buy
3,293
+110
+3% +$25.6K 0.25% 50
2026
Q1
$778K Buy
3,183
+150
+5% +$34.9K 0.26% 50
2025
Q4
$628K Hold
3,033
– – 0.18% 56
2025
Q3
$562K Sell
3,033
-7
-0.2% -$1.2K 0.16% 61
2025
Q2
$464K Sell
3,040
-899
-23% -$138K 0.15% 66
2025
Q1
$653K Sell
3,939
-138
-3% -$21.6K 0.21% 51
2024
Q4
$590K Sell
4,077
-68
-2% -$10.5K 0.2% 56
2024
Q3
$672K Sell
4,145
-141
-3% -$22.5K 0.2% 50
2024
Q2
$626K Sell
4,286
-72
-2% -$10.7K 0.22% 49
2024
Q1
$689K Buy
4,358
+21
+0.5% +$3.34K 0.24% 45
2023
Q4
$680K Sell
4,337
-116
-3% -$17.8K 0.28% 42
2023
Q3
$694K Hold
4,453
– – 0.28% 40
2023
Q2
$737K Sell
4,453
-165
-4% -$26.6K 0.31% 38
2023
Q1
$716K Buy
4,618
+250
+6% +$40.4K 0.29% 34
2022
Q4
$772K Buy
4,368
+29
+0.7% +$5.01K 0.31% 34
2022
Q3
$709K Sell
4,339
-107
-2% -$18.1K 0.39% 34
2022
Q2
$789K Hold
4,446
– – 0.44% 34
2022
Q1
$788K Hold
4,446
– – 0.35% 41
2021
Q4
$761K Buy
+4,446
New +$728K 0.29% 46

Other funds holding JNJ

Kaydan Wealth Management's JNJ Position: Q3 2026 in Review

Kaydan Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.79% in Q3 2026, buying an estimated $6.86K and bringing the position to 3,319 shares worth $879K. The position accounts for 0.3% of the portfolio, ranked #48.

Kaydan Wealth Management first reported a position in JNJ in Q4 2021 and has held it in 20 quarters since. 267 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Kaydan Wealth Management held 3,319 shares of Johnson & Johnson worth $879K as of Q3 2026.
  • Kaydan Wealth Management bought 26 Johnson & Johnson shares in Q3 2026, an estimated $6.86K.
  • Johnson & Johnson made up 0.3% of Kaydan Wealth Management's portfolio in Q3 2026, its #48 holding.
  • Kaydan Wealth Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 20 quarters since.
  • 267 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Kaydan Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.